Skip to main content

ADVERTISEMENT

treatment

Conference Coverage
07/11/2019
Study results presented at the American Headache Society’s 61st Annual Scientific Sessions highlight a non-invasive alternative to opioids for the treatment of chronic migraine.
Study results presented at the American Headache Society’s 61st Annual Scientific Sessions highlight a non-invasive alternative to opioids for the treatment of chronic migraine.
Study results presented at the...
07/11/2019
Neurology
News
07/08/2019
Laura T. Safar, MD, from Brigham and Women's Hospital, answers our questions about the use of psychotropics in patients with multiple sclerosis. Read more about her tips for managing drug-drug interactions here.
Laura T. Safar, MD, from Brigham and Women's Hospital, answers our questions about the use of psychotropics in patients with multiple sclerosis. Read more about her tips for managing drug-drug interactions here.
Laura T. Safar, MD, from Brigham...
07/08/2019
Neurology
News
06/15/2019
Because of its potential to lead to serious consequences, the inadequate treatment of inflammatory bowel disease can be viewed as an adverse event, according to Miguel Regueiro, MD, from Cleveland Clinic. The need for timely, optimal...
Because of its potential to lead to serious consequences, the inadequate treatment of inflammatory bowel disease can be viewed as an adverse event, according to Miguel Regueiro, MD, from Cleveland Clinic. The need for timely, optimal...
Because of its potential to lead...
06/15/2019
Advances in Inflammatory Bowel Disease Network
Podcasts
06/04/2019
Diane Lipscombe, PhD, and Christopher Moore, PhD, from Brown University, discuss their bioluminescence project, how it can affect neurological therapies in the future, and how you can be part of their ongoing research.
Diane Lipscombe, PhD, and Christopher Moore, PhD, from Brown University, discuss their bioluminescence project, how it can affect neurological therapies in the future, and how you can be part of their ongoing research.
Diane Lipscombe, PhD, and...
06/04/2019
Neurology
Editorial
06/01/2019
Terry Treadwell
06/01/2019
Wounds
News
04/24/2019
Do you think switching from a brand-name multiple sclerosis drug to a generic one is safe for patients with the disease? Take our poll to let us know.
Do you think switching from a brand-name multiple sclerosis drug to a generic one is safe for patients with the disease? Take our poll to let us know.
Do you think switching from a...
04/24/2019
Neurology
Conference Coverage
03/06/2019
Guidelines from the American Academy of Neurology recommend stopping disease modifying therapy in those without relapsing MS and who are nonambulatory. Researchers of a study presented at ACTRIMS Forum 2019 analyzed data from 2009 to...
Guidelines from the American Academy of Neurology recommend stopping disease modifying therapy in those without relapsing MS and who are nonambulatory. Researchers of a study presented at ACTRIMS Forum 2019 analyzed data from 2009 to...
Guidelines from the American...
03/06/2019
Neurology
Original Research
04/21/2017
Wounds
News
12/18/2016
Chronic cluster headache is the most disabling form of cluster headache, and current treatment options are not very effective. For this study, researchers evaluated whether sphenopalatine ganglion stimulation is a safe and effective method of...
Chronic cluster headache is the most disabling form of cluster headache, and current treatment options are not very effective. For this study, researchers evaluated whether sphenopalatine ganglion stimulation is a safe and effective method of...
Chronic cluster headache is the...
12/18/2016
Neurology